Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Cristina Mussini and Marianna Menozzi.
Cristina Mussini
Connection Strength
2.323
Marianna Menozzi
  1. The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models. Open Forum Infect Dis. 2021 Jul; 8(7):ofab283.
    View in: PubMed
    Score: 0.238
  2. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.233
  3. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
    View in: PubMed
    Score: 0.231
  4. Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature. Biochem Biophys Res Commun. 2021 01 29; 538:151-155.
    View in: PubMed
    Score: 0.229
  5. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.222
  6. Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection. Infect Dis Rep. 2020 May 29; 12(2):8609.
    View in: PubMed
    Score: 0.220
  7. Incidence of HCV infection amongst HIV positive men who had sex with men and prevalence data from patients followed at the Infectious Diseases Clinic of Modena, Italy. Dig Liver Dis. 2018 12; 50(12):1334-1338.
    View in: PubMed
    Score: 0.193
  8. Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study. AIDS Res Ther. 2017 Feb 16; 14(1):8.
    View in: PubMed
    Score: 0.176
  9. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
    View in: PubMed
    Score: 0.060
  10. Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol. 2021 Nov; 25(11):1203-1214.
    View in: PubMed
    Score: 0.060
  11. Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2022 Feb; 54(2):405-410.
    View in: PubMed
    Score: 0.059
  12. Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients. Kidney Res Clin Pract. 2021 Jun; 40(2):231-240.
    View in: PubMed
    Score: 0.059
  13. Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia. AIDS Res Hum Retroviruses. 2021 04; 37(4):283-291.
    View in: PubMed
    Score: 0.059
  14. Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021 Apr; 25(4):401-409.
    View in: PubMed
    Score: 0.058
  15. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020 12 01; 59(12):e147-e150.
    View in: PubMed
    Score: 0.057
  16. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
    View in: PubMed
    Score: 0.057
  17. Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect. 2020 Nov; 26(11):1545-1553.
    View in: PubMed
    Score: 0.056
  18. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.